Related Experiment Video
Updated: Sep 26, 2026

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
Abstract:
A senior investigator with the National Cancer Institute discusses in this question-and-answer interview some recent findings that a novel human antibody is effective in preventing some strains of HIV from entering CD4 t-cells. The researchers named the newly identified antibody X5 and found that it reacts strongly against a highly conserved region of the glycoprotein gp120.
Insights
A new human antibody, X5, shows promise in blocking certain human immunodeficiency virus (HIV) strains from infecting CD4 T-cells. This antibody targets a critical part of the virus’s outer coat, offering a potential new avenue for HIV prevention.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Human immunodeficiency virus (HIV) primarily targets CD4 T-cells, crucial components of the immune system.
- Effective prevention strategies are vital to control the spread of HIV.
- Understanding viral entry mechanisms is key to developing targeted interventions.
Discussion:
- A novel human antibody, designated X5, has demonstrated efficacy in preventing specific strains of HIV from entering CD4 T-cells.
- The antibody X5 targets a highly conserved region on the viral glycoprotein gp120, a critical component for HIV cell entry.
- This interaction suggests a potential mechanism for blocking viral attachment and subsequent infection.
Key Insights:
- The antibody X5 exhibits potent neutralizing activity against certain HIV strains.
- Identification of X5 provides a new tool for studying HIV-host interactions.
- The conserved region targeted by X5 represents a vulnerable site on the virus.
Outlook:
- Further research into antibody X5 could lead to the development of novel HIV prophylactic or therapeutic agents.
- Exploring the precise binding interactions of X5 may inform the design of next-generation HIV vaccines.
- Clinical evaluation of X5 or similar antibodies could offer new hope in the fight against HIV/AIDS.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
